Skip to main content
. 2020 Oct 15;59(20):2571–2575. doi: 10.2169/internalmedicine.4785-20

Table 1.

mFOLFOX6+Bev Regimen and SOX+Bev Regimen.

Table 1a
mFOLFOX6+Bev (repeated every 2 weeks)
Rp.1 Palonosetron iv 0.75 mg 15 min
Dexart® injection 6.6 mg
Sarine 50 mL
Rp.2 Bevacizumab iv 5 mg/kg 90 min
Sarine 100 mL (after the second time 60 min→30 min)
Rp.3-1 Leucovorin iv 200 mg/m2 120 min
5% glucose solution 250 mL
Rp.3-2 Oxaliplatin iv 85 mg/m2 120 min (co-administration with l-levofolinate)
5% glucose solution 250 mL
Rp.4 Fluorouracil bolus 400 mg/m2 bolus
Sarine 50 mL
Rp.5 Fluorouracil civ 2,400 mg/m2 46 h
Sarine total 230 mL
 
Table 1b
SOX+Bev (repeated every 3 weeks)
Rp.1 Palonosetron iv 0.75 mg 15 min
Dexart® injection 6.6 mg
Sarine 50 mL
Rp.2 Bevacizumab iv 7.5 mg/kg 90 min
Sarine 100 mL (after the second time 60 min→30 min)
Rp.3 Oxaliplatin iv 130 mg/m2 120 min
5% glucose solution 250 mL
Rp.4 Sarine iv 50 mL 15 min
oral cytotoxic agents S-1 po 40-60 mg according to body surface area twice daily for 2 weeks

iv: intravenous injection, bolus: bolus injection, civ: continuous intravenous injection, po: per os